Page last updated: 2024-10-26

doxepin and Seasonal Affective Disorders

doxepin has been researched along with Seasonal Affective Disorders in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Research Excerpts

ExcerptRelevanceReference
"30 inpatients suffering from major depression (DSM-III-R), who did not fulfill the criteria of seasonal affective disorder (SAD), were treated with either doxepin or amitripytyline as monotherapy and supportively with bright light for 14 days."5.08Does bright-light therapy influence autonomic heart-rate parameters? ( Kaschka, WP; Rechlin, T; Schneider, K; Weis, M; Zimmermann, U, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rechlin, T1
Weis, M1
Schneider, K1
Zimmermann, U1
Kaschka, WP1

Trials

1 trial available for doxepin and Seasonal Affective Disorders

ArticleYear
Does bright-light therapy influence autonomic heart-rate parameters?
    Journal of affective disorders, 1995, May-17, Volume: 34, Issue:2

    Topics: Adult; Aged; Amitriptyline; Autonomic Nervous System; Combined Modality Therapy; Doxepin; Female; He

1995